1. The effects shown in the paper require that there be FGF receptors on the corticospinal axons. The authors show that the relevant neurons express the mRNA for these receptors. However many growth factor receptors are restricted to the dendrites of CNS neurons. If the authors can find a suitable antibody, it would be good to see that the receptors are actually present on the CST axons. This manuscript reports that FGF22 signaling through FGFR1 and FGFR2 regulates and is critical for synaptic sprouting that underlies spontaneous functional recovery after hemisection lesions of the spinal cord. The experiments seem rigorously conducted and well controlled. The data figures are of good quality and the data presented are convincing. The conclusions seem reasonable and not overstated. The findings are interesting and advance information regarding factors that regulate synaptic reorganization associated with spontaneous recovery after partial SCI and that might be targeted for therapeutic interventions. I have only some minor concerns.
The description of what the authors mean by a "dorsal hemisection" should be more detailed and should not simply refer to previous papers. Does "dorsal hemisection" means that the spinal cord was cut on both sides (bilaterally) but only part way down? If so, how far down, and how reproducible or consistent is the cut to the same depth. It will only take a few words to make this clear. Also, does this cut interfere with at least some of the propriospinal projections? This should be discussed more clearly. Lastly, the text on page 4 and 5 should make it more clear that the sprouting of CST is being studied in the cervical region after the transection of the CST at T8. At least this is my interpretation of what is shown. The main text is too short and vague in this regard. The authors may think that it is obvious, but it is not. (1.0) Plasticity and the creation of bypass circuits is the main mechanism of functional recovery after spinal cord injury. The paper demonstrates a role for FGF22 signalling in this process. The experiments are thorough and well-performed. If space permits, more detail would improve the readability of the paper.
We thank the reviewer for his/her positive assessment of our work and, as suggested, we have added experimental details to the results section and expanded the discussion section in the revised manuscript.
(1.1) The effects in the paper require that there be FGF receptors on corticospinal axons. The authors show that the relevant neurons express the mRNA for these receptors. However many growth factor receptors are restricted to the dendrites of CNS neurons. If the authors find a suitable antibody, it would be good to see that the receptors are actually present on the CST axons.
As suggested by the reviewer we have searched for appropriate antibodies that allow immuostaining for FGFR1 and FGFR2 on PFA-fixed cryosections. While we did not find suitable FGFR1 antibodies, we could perform immunostainings for FGFR2. We first confirmed the specificity of the FGFR2 antibody by comparing the staining pattern on tissue from FGFR2 competent and forebrain FGFR2 deficient mice ( Figure We agree with the reviewer that it would be helpful to know whether the newly formed CST boutons co-localize with a post-synatic marker. To address this question, we have now performed immunostainings for PSD95 (Synaptic Systems PSD95 124 011), an established marker of postsynaptic densities. Our results show that indeed CST boutons commonly co-localize with PSD95-positive densities (see Reviewer Figure 1 ). However the very high density of PSD95-positive structures in the cervical grey matter makes it very difficult to specifically assign post-synaptic densities to individual CST boutons and to our mind unfortunately preclude a reliable quantitative analysis in our system. (1.4) In the assays of sprouting the authors counted the number of sprouts exiting the dorsal columns. Were there any obvious differences in the length of the sprouts? Following the reviewer's suggestion we have gone back to our data and compared the length of the collaterals that exited the CST in the different FGF and FGFR deficient mouse lines and their respective control groups. Our analysis shows that there are no significant differences in the length of individual CST collaterals between these groups. We now present these results in a new expanded view figure ( Figure E2 ) and include them in the revised results section of the manuscript (p. 6) (1.5) Why do the authors think that there is no apparent developmental effect of the FGF22 knockout, where the references cited are all about developmental defects. The reviewers raises an interesting point, namely why we did not detect differences in CST development in FGF 22 deficient mice despite the fact that developmental alterations in other parts of the nervous system have been previously described in these mice [1] [2] [3] . There are a number of possible explanation for our finding: i) It might be that the developmental defects in FG22 deficient mice are cell-type specific and thus present in some neurons e.g. in the cerebellum 1 , the dorsal lateral geniculate nucleus 2 and the hippocampus 3 but not in others like the corticospinal projection neurons. ii) It is possible that corticospinal neurons show initial developmental defects that are however compensated over time and would thus not be detected by our analysis that was performed in adult mice (at 6 weeks of age). The finding that newly formed CST synapses in FGF22 deficient mice still show some maturation between 3 and 12 weeks after lesion (Figure 5 ) would be compatible with such as delayed compensation process. iii) Finally it is conceivable that the CST shows developmental defects that are however not detected by our anatomical analysis. Subtle synaptic deficits for example of the composition of the pre-synaptic vesicle pool that affect neither overall locomotor function nor collateral morphology or synapse number would not be detected by our analysis. We now discuss this important aspect in the revised discussion and explicitely mention the limitations of our analysis of normal CST development (p. 9/10).
(1.6) Do the authors have an explanation for the compensatory increase in the sprouting of CST axons in the single FGF receptor knockdowns? This is another very good question by the reviewer. As this compensatory response is only observed in single FGF receptor deficient mice (both after viral and genetic deletion) but neither in FGF22 deficient nor in the hindlimb motor cortex FGFR1 and FGFR2 double-deficient mice there are to our mind two possible explanations: (i) FGF22 itself has a pro-sprouting effect that can be mediated by either FGFR1 or FGFR2 and is thus present in both single receptor deficient mice but absent when the ligand or both receptors are missing. (ii) The induction of the compensatory response requires the presence of at least some "mature" and thus likely functional synapses on the corresponding CST collateral. As synapse maturation deficits are more pronounced in the FGF22 deficient and the hindlimb motor cortex FGFR1 and FGFR2 double-deficient mice ( Figure 5) this could prevent the induction of such compensatory response. While it is difficult to definitively resolve this question in our system we now discuss the possible explanations in the revised discussion (p. 8/9) of the manuscript.
Reviewer #2 (2.0) The manuscript reports that FGF22 signaling through FGFR1 and FGFR2 regulates and is critical for synaptic sprouting that underlies spontanous functional recovery after hemisection lesions of the spinal cord. The experiments seem rigorously conducted and well controlled. The data figures are of good quality and the data presented are convincing. The conclusions seem reasonable and not overstated. The findings are interesting and advance information regarding factors that regulate synaptic reorganization associated with spontanous recovery after partial SCI and that might be targeted for therapeutic interventions.
We thank the reviewer for his/her positive assessment of our work.
(2.1)
The description of what the authors mean by a "dorsal hemisection" should be more detailed and should not simply refer to previous papers. Does "dorsal hemisection" mean that the spinal cord was cut on both sides (bilaterally) but only part the way down? If so, how far down, and how reproducible or consistent is the cut to the same depth. It will only take some words to make this clear. This indicates that FGF22 signaling does not interfere with lesion formation and thus the observed differences in locomotor recovery are likely related to an altered axonal remodeling response to the lesion and not to a primary difference in the number of lesioned axons. (iii) Finally, two lines of arguments support the view that propriospinal connections are not affected by the lesion. First, as described above we have examined the dorso-lateral lesion extent and confirmed that none of the lesions reaches the ventral white matter that contains the propriospinal axons (Reviewer Figure  2A,B) . Additionaly we counted the number of retrogradely traced propriospinal neurons in the cervical spinal cord of lesioned mice and unlesioned control mice and found similar number of labelled neurons again indicating that propriospinal axons that retrogradely transport the dye from the lumbar injection site are not transected by the thoracic dorsal bilateral hemisection (Reviewer Figure 2D) . In the revised manuscript we now use the more precise term "thoracic dorsal bilateral hemisection" whenever we refer to the lesion model and better explain the lesion extension in this model in the revised methods section (p. 14). We also present the quantification of the lesion volumes in the different experimental groups in the results section (p. 7) and of the labeled propriospinal neurons in lesioned and unlesioned mice in the revised methods section (p. 15/16).
(2.3)
Lastly the text on page 4 and 5 should make it more clear that the sprouting of CST is being studied in the cervical region after transection of the CST a T7. At least this is my interpretation of what is shown. The main text is too short and vague in this regard. The authors might think that it is obvious but it is not. Indeed CST sprouting was always analysed in the cervical spinal cord after a dorsal bilateral hemisection of the CST at T8. As also suggested by the editor and reviewer 1 we have now extended the results section of the manuscript and provide more details on the way experiments were performed including the information where the CST was lesioned and where sprouting was analysed.
